Shivon Zilis Archives

Business

Elon Musk’s partner Shivon Zilis announces breakup after years together

By Norman Pearlstine

Shivon Zilis, a former Tesla executive and current Neuralink employee, posted on X that her long‑term relationship with Elon Musk has ended.

Comments closed

10-Year Treasury Yield Hits Highest Level Since 2002, Raising Borrowing Costs

By Mitchell Landsberg

The 10-year Treasury yield climbed to 5.34% on Thursday, its highest level since 2002, prompting higher borrowing costs for households and businesses while offering better returns for savers.

Comments closed

Iren and Micron emerge as top AI‑centric growth stocks for $1,000 investors

By Helene Elliott

Investors with $1,000 to spare may look to Iren and Micron, two firms positioned to profit from the expanding AI data‑center market.

Comments closed

Retatrutide Shows 25% Average Weight Loss in Late‑Stage Trial

By Norman Pearlstine

In a phase 3 study of 2,339 adults, weekly retatrutide injections produced up to 25% average weight loss after 80 weeks and improved knee pain and sleep apnea.

Comments closed

OpenAI safety leader David Robinson resigns amid ongoing staff turnover

By Mitchell Landsberg

OpenAI’s safety systems leader David Robinson has left the company, adding to a series of recent departures in its AI safety ranks.

Comments closed

Science

Elon Musk’s partner Shivon Zilis announces breakup after years together

By Norman Pearlstine

Shivon Zilis, a former Tesla executive and current Neuralink employee, posted on X that her long‑term relationship with Elon Musk has ended.

Comments closed

10-Year Treasury Yield Hits Highest Level Since 2002, Raising Borrowing Costs

By Mitchell Landsberg

The 10-year Treasury yield climbed to 5.34% on Thursday, its highest level since 2002, prompting higher borrowing costs for households and businesses while offering better returns for savers.

Comments closed

Iren and Micron emerge as top AI‑centric growth stocks for $1,000 investors

By Helene Elliott

Investors with $1,000 to spare may look to Iren and Micron, two firms positioned to profit from the expanding AI data‑center market.

Comments closed

Retatrutide Shows 25% Average Weight Loss in Late‑Stage Trial

By Norman Pearlstine

In a phase 3 study of 2,339 adults, weekly retatrutide injections produced up to 25% average weight loss after 80 weeks and improved knee pain and sleep apnea.

Comments closed

OpenAI safety leader David Robinson resigns amid ongoing staff turnover

By Mitchell Landsberg

OpenAI’s safety systems leader David Robinson has left the company, adding to a series of recent departures in its AI safety ranks.

Comments closed